These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16406843)

  • 1. Emerging medicinal roles for lysophospholipid signaling.
    Gardell SE; Dubin AE; Chun J
    Trends Mol Med; 2006 Feb; 12(2):65-75. PubMed ID: 16406843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophospholipid activation of G protein-coupled receptors.
    Mutoh T; Chun J
    Subcell Biochem; 2008; 49():269-97. PubMed ID: 18751915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophospholipid receptors in drug discovery.
    Kihara Y; Mizuno H; Chun J
    Exp Cell Res; 2015 May; 333(2):171-177. PubMed ID: 25499971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases.
    Chun J; Rosen H
    Curr Pharm Des; 2006; 12(2):161-71. PubMed ID: 16454733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
    Peyruchaud O
    Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface receptors in lysophospholipid signaling.
    Anliker B; Chun J
    Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
    Tian YL; Jin J; Wang XJ
    Yao Xue Xue Bao; 2012 Jan; 47(1):7-17. PubMed ID: 22493799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.
    Proia RL; Hla T
    J Clin Invest; 2015 Apr; 125(4):1379-87. PubMed ID: 25831442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the sphingosine-1-phosphate signalling system.
    Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
    Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophospholipids--receptor revelations.
    Hla T; Lee MJ; Ancellin N; Paik JH; Kluk MJ
    Science; 2001 Nov; 294(5548):1875-8. PubMed ID: 11729304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
    Lee CW; Choi JW; Chun J
    Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
    Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
    Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The organization of the sphingosine 1-phosphate signaling system.
    Rosen H; Germana Sanna M; Gonzalez-Cabrera PJ; Roberts E
    Curr Top Microbiol Immunol; 2014; 378():1-21. PubMed ID: 24728591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing.
    Watterson KR; Lanning DA; Diegelmann RF; Spiegel S
    Wound Repair Regen; 2007; 15(5):607-16. PubMed ID: 17971005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer.
    Murph M; Tanaka T; Liu S; Mills GB
    Clin Cancer Res; 2006 Nov; 12(22):6598-602. PubMed ID: 17121877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system.
    Goetzl EJ; Wang W; McGiffert C; Huang MC; Gräler MH
    J Cell Biochem; 2004 Aug; 92(6):1104-14. PubMed ID: 15258896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate and lysophosphatidic acid receptors: agonist and antagonist binding and progress toward development of receptor-specific ligands.
    Parrill AL; Sardar VM; Yuan H
    Semin Cell Dev Biol; 2004 Oct; 15(5):467-76. PubMed ID: 15271292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.